Search filters

List of works by Prudence Ive

Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes

scientific article published on 4 December 2017

Clinical and Genetic Determinants of Plasma Nevirapine Exposure Following an Intrapartum Dose to Prevent Mother-to-Child HIV Transmission

scientific article published on May 17, 2013

Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa

scientific article published on 26 September 2016

Does Disseminated Nontuberculous Mycobacterial Disease cause False-positive Determine TB-LAM Lateral Flow Assay Results?

scientific article published on 4 October 2017

Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review

scientific article published on 2 June 2017

Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries

scientific article published on May 2012

Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?

scientific article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

scientific article published on 27 October 2011

Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

scientific article

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

scientific article published on March 2014

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resista

scientific article published on 18 March 2015

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes

scientific article published on October 2013

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa

scientific article

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection

scientific article

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa

scientific article

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa

scientific article

Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa

scientific article published on 7 July 2016

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial

scientific article

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy

scientific article published on 18 November 2011

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection

scientific article published on March 2010

Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.

scientific article

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection

scientific article

NeuroAIDS in Africa

scientific article published on May 2010

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

scientific article

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

scientific article published on April 3, 2012

Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study

scientific article

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

scientific article published on 10 April 2018

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

scientific article published in Scientific Reports

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study

scientific article published on April 16, 2013

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

scientific article published on August 2011

Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies

scientific article published on 7 February 2016

Reply to Gupta-Wright et al.

scientific article published on 17 August 2017

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

scientific article published in July 2004

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa

scientific article published on 23 March 2012

Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update

scientific article published on 08 November 2019

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

scientific article published on 15 March 2018

The feasibility of using screening criteria to reduce clinic visits for stable patients on antiretroviral therapy in South Africa

scientific article published on March 2013

The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study

scientific article published on 13 June 2018

The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa

scientific article published on 01 August 2020

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

scientific article published in October 2011

Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells

scientific article

Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs

scientific article published on April 2014

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

scientific article